Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the platelet antiaggregant effect that a chronic
treatment with ASA (150 mg) produces,comparing this effect between two formulations of ASA:
normal and the one of sustained release, in patients with stable coronary disease.